Global In Vivo Electroporation Instrument Market, By Application (Biomedical research and Therapeutics), By End-user (Biotechnology and Pharmaceuticals company, Hospital, Academic Research and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Electroporation is a biotechnological procedure that involves passing an electric current through a live surface, such as a cell or a molecule. Pores emerge on the surface of the living structure in this fashion, allowing biological material to pass through readily. This method is commonly used to introduce viruses or plasmids into cells via pores in the cell membrane in the form of vectors or plasmids. Electroporation of the cell membrane occurs when cells are exposed to an electric field, and it has been researched and employed in a variety of applications in medicine and food biotechnology (e.g. electrochemotherapy, gene electrotransfer, extraction of biomolecules). Electroporation in vivo has become a popular method for creating nonviral gene treatments and nucleic acid vaccinations (NAV). The development of effective and nontoxic polynucleotide delivery systems is critical for the future of gene therapy. There are several methods for gene delivery, and in vivo gene transfer is currently divided into two categories: viral and non-viral delivery. In vivo electroporation (EP) is a technique for delivering bare plasmid DNA genes into living cells. The Global Biometric Sensors Market accounted for US$ 128 Million 2020 and is estimated to be US$ 230.43 million by 2030 and is anticipated to register a CAGR of 6.1%.

Increasing Demand for In-vivo Electroporation to Transfer Dyes, Ions, Nucleic Acids across Cell Membrane to Aid Market Growth

Technological advancements and R&D activities have played an imperative role in bringing about groundbreaking changes across the healthcare sector. The entry of new technologies has paved the way for cutting-edge medical devices that are increasingly being used to treat an array of medical diseases and conditions. Over the past couple of decades, major developments have occurred across the electroporation instruments market landscape, as market players continue to focus on improving the efficiency and performance of their products. Electroporation is an established physical technique that is primarily used to introduce polar molecules, including DNA into eukaryotic cells via the cell membrane.

As advancements in gene-editing techniques occur at a consistent pace, the prospects of the electroporation instruments market continue to stare at a bright future. Furthermore, with considerable growth in the research and development expenditure, electroporation is extensively being used to deliver chemotherapy drugs and gene electro transfer– factors that are expected to boo Furthermore, as electroporation penetrates 3D structures with high levels of efficiency, advanced gene editing techniques are likely to gain further traction in the upcoming decade.

Non-specific Transport and Other Damages to Hamper In-vivo electroporation Instruments Market

In-vivo electroporation methods have few disadvantages compared to other delivery systems

In some cases, non-specific transport of the material can result in an ion imbalance, which could lead to improper cell function and death. Irreversible electroporation could lead to loss of cell homeostasis, widely considered as unconventional mode for cell death.

In-vivo electroporation method causes complication and skin edema, as compared to other physical methods.

In other chemical methods, instruments are not required, which are highly preferred by some researchers. However, in some instances, electroporation effectiveness is widely influenced by other factors such as cell or tissue type and DNA formulation.

The method has some disadvantages, as there exists the potential for immunogenicity, random insertion and its mutagenesis in the genome, uncontrollable chronic expression of the gene, risk of systemic spread, and the fact that the quality control of viral particles for in vivo administration is a laborious and expensive protocol.3 In contrast, non-viral gene delivery is believed to be safer than viral delivery, and it has been shown that efficient and long-term expression could be expected.

 

 

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

 

 

Source: Prophecy Market Insights

The global In Vivo Electroporation Instrument market is segmented based on application, end-user and region.

On the basis of Application, the global In vivo electroporation instrument market is segmented into Biomedical research and Therapeutics. Based on End-user, the target market is segmented into Biotechnology and Pharmaceuticals company, Hospital, Academic Research and Others.

Regional Insights:

On region the global In vivo electroporation instrument market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Presence of highly modern research facilities and diagnostic clinics, North America is expected to have the biggest market share for electroporation instruments, followed by Europe. Furthermore, the federal government's proper and advantageous reimbursement rules encourage people to use these electroporation tools. Electroporation was originally utilized in medicine to deliver anticancer medications to tumor nodules that were poorly permeable. Gene electrotransfer quickly gained popularity because to its inexpensive cost, ease of implementation, and safety.

 

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD Million & CAGR from 2020 – 2030
Market Segmentation	By Application- Biomedical Research and Therapeutics By End-user– Biotechnology and Pharmaceuticals company, Hospital, Academic Research and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global In vivo electroporation instrument market report based on application, and region.

Global In vivo Electroporation Instrument Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global In vivo electroporation instrument market includes Thermo Fisher Scientific, Inc., Merck, Lonza group, BEX, Celetrix LLC., Eppendorf AG, Harvard Bioscience Inc., Maxcyte Inc., Mirus Bio LLC, and Bio Rad laboratories. The companies are focusing on acquisitions and collaboration strategies to strengthen its market, which is expected to fuel the markets growth.

• Thermo Fisher Scientific, Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Merck
• Lonza group
• BEX
• Celetrix LLC.
• Eppendorf AG
• Harvard Bioscience Inc.
• Maxcyte Inc.
• Mirus Bio LLC
• Bio Rad laboratories VIRCELL S.L.

 “*” marked represents similar segmentation in other categories in the respective section

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for In Vivo Electroporation Instrument Market Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Application
     • Market Snippet, By End-user
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Global In Vivo Electroporation Instrument Market, By Application, 2020 – 2030, (US$ Mn)
   • Biomedical Research
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Therapeutics
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
6. Global In Vivo Electroporation Instrument Market, By End-user, 2020 – 2030, (US$ Mn)
   • Biotechnology and Pharmaceutical company
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Hospital
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Academic and Research
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
7. Global In Vivo Electroporation Instrument Market, By Region, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
       • Germany
       • UK
       • France
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
       • China
       • India
       • Japan
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End User, 2020 – 2030
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
8. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
9. Company Profiles
   • Thermo Fischer Scientific Inc.*
     • • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Business Strategies
   • Merck Ga A
   • Lonza Group
   • BEX
   • Celetrix LLC.
   • Eppendorf AG
   • Harvard Bioscience Inc.
   • Maxcyte Inc.
   • Mirus Bio LLC
   • Bio Rad laboratories VIRCELL S.L.

The Last Word

• • Future Impact
  • About Us
  • Contact